Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Chia Tai Tianqing Pharmaceutical
Chia Tai Tianqing Pharmaceutical
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Fosaprepitant dimeglumine
Fosaprepitant dimeglumine
2021-03-03
—
Fulvestrant
Fulvestrant
2020-02-07
2034
Breast neoplasms
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Fulvestrant
healthy volunteers/patients
Eribulin
lymphoma
,
skin neoplasms
,
cutaneous malignant melanoma
,
abdominal neoplasms
,
retroperitoneal neoplasms
,
renal insufficiency
,
ovarian neoplasms
,
lung neoplasms
,
ovarian epithelial carcinoma
,
prostatic neoplasms
,
liposarcoma
,
inflammatory breast neoplasms
,
melanoma
,
head and neck neoplasms
,
leiomyosarcoma
,
colorectal neoplasms
,
urethral neoplasms
,
ureteral neoplasms
,
renal cell carcinoma
,
fallopian tube neoplasms
,
ewing sarcoma
,
rhabdomyosarcoma
,
pancreatic neoplasms
,
pelvic neoplasms
,
colonic neoplasms
,
fatigue
,
circulating neoplastic cells
,
postmenopause
,
soft tissue neoplasms
,
malignant fibrous histiocytoma
,
residual neoplasm
,
solitary fibrous tumors
,
hemangiopericytoma
,
fibrous tissue neoplasms
,
hemangiosarcoma
,
epithelioid hemangioendothelioma
,
osteosarcoma
,
uterine cervical neoplasms
,
salivary gland neoplasms
,
castration-resistant prostatic neoplasms
,
uterine neoplasms
,
carcinosarcoma
,
mullerian mixed tumor
,
hepatocellular carcinoma
,
drug therapy
,
triple negative breast neoplasms
,
neoplasms
,
sarcoma
,
neoplasm metastasis
,
recurrence
,
carcinoma
,
non-small-cell lung carcinoma
,
brain neoplasms
,
urologic neoplasms
,
urinary bladder neoplasms
,
transitional cell carcinoma
,
hereditary breast and ovarian cancer syndrome
,
adenocarcinoma
,
brca2 genes
,
invasive hydatidiform mole
,
meningeal neoplasms
,
meningeal carcinomatosis
,
mutation
,
breast neoplasms
,
neurotoxicity syndromes
,
male breast neoplasms
,
drug-related side effects and adverse reactions
,
peripheral nervous system diseases
,
alopecia areata
,
alopecia
,
treatment outcome
,
gastrointestinal neoplasms
Eribulin mesylate
lymphoma
,
skin neoplasms
,
cutaneous malignant melanoma
,
abdominal neoplasms
,
retroperitoneal neoplasms
,
renal insufficiency
,
ovarian neoplasms
,
lung neoplasms
,
ovarian epithelial carcinoma
,
prostatic neoplasms
,
liposarcoma
,
inflammatory breast neoplasms
,
melanoma
,
head and neck neoplasms
,
leiomyosarcoma
,
colorectal neoplasms
,
urethral neoplasms
,
ureteral neoplasms
,
renal cell carcinoma
,
fallopian tube neoplasms
,
ewing sarcoma
,
rhabdomyosarcoma
,
pancreatic neoplasms
,
pelvic neoplasms
,
colonic neoplasms
,
fatigue
,
circulating neoplastic cells
,
postmenopause
,
soft tissue neoplasms
,
malignant fibrous histiocytoma
,
residual neoplasm
,
solitary fibrous tumors
,
hemangiopericytoma
,
fibrous tissue neoplasms
,
hemangiosarcoma
,
epithelioid hemangioendothelioma
,
osteosarcoma
,
uterine cervical neoplasms
,
salivary gland neoplasms
,
castration-resistant prostatic neoplasms
,
uterine neoplasms
,
carcinosarcoma
,
mullerian mixed tumor
,
hepatocellular carcinoma
,
drug therapy
,
triple negative breast neoplasms
,
neoplasms
,
sarcoma
,
neoplasm metastasis
,
recurrence
,
carcinoma
,
non-small-cell lung carcinoma
,
brain neoplasms
,
urologic neoplasms
,
urinary bladder neoplasms
,
transitional cell carcinoma
,
hereditary breast and ovarian cancer syndrome
,
adenocarcinoma
,
brca2 genes
,
invasive hydatidiform mole
,
meningeal neoplasms
,
meningeal carcinomatosis
,
mutation
,
breast neoplasms
,
neurotoxicity syndromes
,
male breast neoplasms
,
drug-related side effects and adverse reactions
,
peripheral nervous system diseases
,
alopecia areata
,
alopecia
,
treatment outcome
,
gastrointestinal neoplasms
Sacituzumab
breast neoplasms
Mycophenolate sodium
multiple sclerosis
,
relapsing-remitting multiple sclerosis
,
lupus nephritis
,
nephritis
Benzimidazole
healthy volunteers/patients
,
rheumatoid arthritis
,
arthritis
,
drug interactions
,
leukemia
,
b-cell chronic lymphocytic leukemia
,
lymphoid leukemia
,
alzheimer disease
,
prostatic neoplasms
,
carcinoma
,
small cell carcinoma
,
neuroendocrine carcinoma
,
hodgkin disease
,
lymphoma
,
neoplasms
,
t-cell lymphoma
,
t-cell lymphoma peripheral
,
hematoma
,
graft rejection
,
atrial fibrillation
,
thrombosis
,
embolism
Sintilimab
breast neoplasms
,
triple negative breast neoplasms
Penpulimab
colorectal neoplasms
,
stomach neoplasms
,
squamous cell carcinoma of head and neck
,
pancreatic neoplasms
,
esophageal squamous cell carcinoma
,
squamous cell carcinoma
,
large b-cell lymphoma diffuse
,
sarcoma
,
gastrointestinal neoplasms
,
thyroid neoplasms
,
breast neoplasms
,
triple negative breast neoplasms
,
recurrence
,
rectal neoplasms
,
pheochromocytoma
,
urologic neoplasms
,
digestive system neoplasms
,
gastrointestinal stromal tumors
,
neuroendocrine tumors
,
small cell lung carcinoma
,
female genital neoplasms
,
glioblastoma
,
uterine cervical neoplasms
,
neoplasms by histologic type
,
male breast neoplasms
,
essential tremor
,
head and neck neoplasms
,
neoplasm metastasis
,
syndrome
,
gastrointestinal diseases
,
digestive system diseases
,
paraganglioma
,
osteosarcoma
,
b-cell lymphoma
,
melanoma
,
esophageal neoplasms
,
adenocarcinoma
,
neoadjuvant therapy
,
immunotherapy
,
neoplasms
,
carcinoma
,
lung neoplasms
,
hepatocellular carcinoma
,
liver neoplasms
,
nasopharyngeal carcinoma
,
nasopharyngeal neoplasms
,
lymphoma
,
squamous cell neoplasms
,
hodgkin disease
,
hypersensitivity
,
non-small-cell lung carcinoma
,
urinary bladder neoplasms
,
transitional cell carcinoma
,
small cell carcinoma
,
thyroid diseases
Lanifibranor
pharmacokinetics
Gilvetmab
neoplasms
,
non-hodgkin lymphoma
,
lymphoma
,
non-small-cell lung carcinoma
Enoblituzumab
prostatic neoplasms
,
castration-resistant prostatic neoplasms
,
carcinoma
,
hepatocellular carcinoma
,
liver neoplasms
Efbemalenograstim alfa
non-small-cell lung carcinoma
,
lung neoplasms
,
febrile neutropenia
,
colorectal neoplasms
,
pancreatic neoplasms
,
ovarian neoplasms
,
uterine cervical neoplasms
,
neutropenia
,
breast neoplasms
,
neoplasms
Aglatimagene besadenovec
renal cell carcinoma
,
colonic neoplasms
,
bone diseases
,
urethral neoplasms
,
transitional cell carcinoma
,
neoplasms
,
non-small-cell lung carcinoma
,
breast neoplasms
,
lung neoplasms
,
carcinoma
,
urinary bladder neoplasms
,
urologic neoplasms
,
neoplasm metastasis
,
melanoma
,
ovarian neoplasms
,
uterine cervical neoplasms
,
small cell lung carcinoma
,
small cell carcinoma
,
endometrial neoplasms
,
adenocarcinoma
,
triple negative breast neoplasms
,
neuroendocrine tumors
,
colorectal neoplasms
,
hepatocellular carcinoma
,
liver neoplasms
,
squamous cell carcinoma
,
squamous cell carcinoma of head and neck
,
x-linked bulbo-spinal atrophy
,
recurrence
,
pancreatic neoplasms
,
stomach neoplasms
,
head and neck neoplasms
,
esophageal neoplasms
,
prostatic neoplasms
,
hyperplasia
,
castration-resistant prostatic neoplasms
,
prostatic hyperplasia
Spartalizumab
ovarian neoplasms
,
lung neoplasms
,
neoplasm metastasis
,
kidney neoplasms
,
leukemia
,
myeloid leukemia acute
,
hematologic diseases
,
myeloid leukemia
,
myelomonocytic leukemia juvenile
,
preleukemia
,
bone marrow diseases
,
syndrome
,
colonic neoplasms
,
rectal neoplasms
,
essential thrombocythemia
,
polycythemia vera
,
primary myelofibrosis
,
thrombocytosis
,
polycythemia
,
glioblastoma
,
multiple myeloma
,
plasma cell neoplasms
,
alveolar soft part sarcoma
,
chordoma
,
neoplasms
,
non-small-cell lung carcinoma
,
triple negative breast neoplasms
,
colorectal neoplasms
,
carcinoma
,
breast neoplasms
,
renal cell carcinoma
,
pancreatic neoplasms
,
hepatocellular carcinoma
,
lymphoma
,
liver neoplasms
,
squamous cell carcinoma of head and neck
,
squamous cell carcinoma
,
adenocarcinoma
,
esophageal squamous cell carcinoma
,
squamous cell neoplasms
,
pancreatic ductal carcinoma
,
myelodysplastic syndromes
,
myelomonocytic leukemia chronic
,
ovarian epithelial carcinoma
,
gastrointestinal stromal tumors
,
sarcoma
,
anus neoplasms
,
small cell lung carcinoma
,
nasopharyngeal carcinoma
,
nasopharyngeal neoplasms
,
prostatic neoplasms
,
large b-cell lymphoma diffuse
,
neuroendocrine tumors
,
urologic neoplasms
,
thyroid neoplasms
,
esophageal neoplasms
,
uterine cervical neoplasms
,
cholangiocarcinoma
,
unknown primary neoplasms
,
adenocarcinoma of lung
,
clear cell adenocarcinoma
,
mesothelioma
,
carcinosarcoma
,
uveal neoplasms
,
adenomyoepithelioma
,
uveal melanoma
,
hematologic neoplasms
,
castration-resistant prostatic neoplasms
,
b-cell lymphoma
,
head and neck neoplasms
,
non-hodgkin lymphoma
,
neuroendocrine carcinoma
,
endometrial neoplasms
,
anaplastic thyroid carcinoma
,
melanoma
,
skin neoplasms
Lenograstim
recurrence
,
biphenotypic leukemia acute
,
myeloid leukemia acute
,
lymphoma
,
leukemia
,
myeloid leukemia
1
2
3
4
5
6
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use